Macomb Regional Dialysis Center is a medicare approved dialysis facility center in Clinton Township, Michigan and it has 20 dialysis stations. It is located in Macomb county at 16151 19 Mile Rd, Clinton Township, MI, 48038. You can reach out to the office of Macomb Regional Dialysis Center at (586) 263-8350. This dialysis clinic is managed and/or owned by Greenfield Health Systems. Macomb Regional Dialysis Center has the following ownership type - Profit. It was first certified by medicare in January, 2008. The medicare id for this facility is 232642 and it accepts patients under medicare ESRD program.
| Name | Macomb Regional Dialysis Center |
|---|---|
| Location | 16151 19 Mile Rd, Clinton Township, Michigan |
| No. of Dialysis Stations | 20 |
| Medicare ID | 232642 |
| Managed By | Greenfield Health Systems |
| Ownership Type | Profit |
| Late Shifts | No |
| 16151 19 Mile Rd, Clinton Township, Michigan, 48038 | |
| (586) 263-8350 | |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| NPI Number | 1689870594 |
| Doing Business As | Macomb Regional Dialysis Centers, L.l.c. |
| Address | 16151 Ninteen Mile Rd Clinton Township, Michigan, 48038 |
| Phone Number | (586) 263-8350 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 59% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 10% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 31% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 52% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 26% | 14% |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 64% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 15% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 21% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 67% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 6% | 12% |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 88% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 12% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 77% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 58 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 36 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 106 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 859 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Pediatic patients getting regular hemodialysis at the center | 1 |
| Pediatric patient months included in in Kt/V greater than or eqaul to 1.2 | 1 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 321 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 92 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Macomb Regional Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 140 |
| Hypercalcemia patient months | 1224 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 152 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 74 |
| Patient months included in arterial venous fistula and catheter summaries | 581 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 53 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 19 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 109 |
| Hospitalization Rate in facility | 236 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 365.8 |
| Hospitalization Rate: Lower Confidence Limit | 162.7 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Macomb Regional Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 31.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 42.8 |
| Readmission Rate: Lower Confidence Limit | 21.4 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Macomb Regional Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .32 (Better than Expected) |
| SIR: Upper Confidence Limit | .87 |
| SIR: Lower Confidence Limit | .08 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Macomb Regional Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 86 |
| Transfusion Rate in facility | 49.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 101.6 |
| Transfusion Rate: Lower Confidence Limit | 26.2 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Macomb Regional Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 530 |
| Mortality Rate in facility | 15.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.4 |
| Mortality Rate: Lower Confidence Limit | 11.9 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago
FMC Dialysis - Clinton Location: 35351-a Gratiot Ave, Clinton Township, Michigan, 48035 Phone: (586) 791-6203 |
Macomb Regional Dialysis Center Location: 16151 19 Mile Rd, Clinton Township, Michigan, 48038 Phone: (586) 263-8350 |
Clinton Township Dialysis Of Davita Location: 15918 Nineteen Mile Rd, Clinton Township, Michigan, 48038 Phone: (586) 412-9195 |
News Archive
IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
There were about 247 million malaria cases worldwide in 2006, according to the World Malaria Report 2008, which was released by the World Health Organization on Thursday, Reuters reports (MacInnis, Reuters, 9/18). According to the report, 3.3 billion people worldwide were at risk for malaria in 2006, and the disease remains a major burden among children younger than age five and in many African countries (AFP/Google.com, 9/18).
A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.
› Verified 2 days ago